Convulxin from Santa Cruz Biotechnology, Inc.

Product Specs
ItemConvulxin
CompanySanta Cruz Biotechnology, Inc.
Price $816.00Supplier Page View Company Product Page
Catalog Numbersc-202554
Quantity50 µg
TypeBiochemical Reagents
Molecular Weight~84 kDa

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Role of Rubicon in platelets: a promoter of thrombosis but not an autophagy repressorBlood AdvancesFebruary 24, 2026Hammodah R. Alfar, Elizabeth R. Driehaus, Alexis N. Smith, Daniëlle Marije Coenen, Dlovan F. D. D Mahmood, Jeremy P. Wood, Sidney W. WhiteheartU/mL; Chrono-Log, catalog no. P/N 386) and convulxin (100 ng/mL; Santa Cruz Biotechnology, catalog no. sc-202554) for 1 hour at 37°C. More details are available in the supplemental Material. Flow cytometry Washed

(2) Neutrophil glucose flux as a therapeutic target in antiphospholipid syndromeJournal of Clinical InvestigationAugust 1, 2024Ajay Tambralli, Alyssa Harbaugh, Somanathapura K. NaveenKumar, Megan D. Radyk, Christine E. Rysenga, Kaitlyn Sabb, Julia M. Hurley, Gautam J. Sule, Srilakshmi Yalavarthi, Shanea K. Estes, et al.washed platelets (1×108) were stimulated with and without convulxin (50 ng/mL, Santa Cruz Biotechnology sc-202554) or PAR4 agonist peptide (50 μM, Sigma-Aldrich A3227) for 15 minutes and fixed with 2% paraformaldehyde.

(3) Neutrophil extracellular trap inhibition improves survival in neonatal mouse infectious peritonitisPediatric researchMarch 1, 2023Denorme F, Rustad JL, Portier I, Crandell JL, de Araujo CV, Cody MJ, Campbell RA, Yost CC.

(4) RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defectsBloodJanuary 19, 2023Lee K, Ahn HS, Estevez B, Poncz M.

(5) Luteolin inhibits GPVI-mediated platelet activation, oxidative stress, and thrombosisFrontiers in pharmacologyJanuary 1, 2023Ye Y, Yang L, Leng M, Wang Q, Wu J, Wan W, Wang H, Li L, Peng Y, Chai S, et al.Havertown, Pennsylvania, United States; U46619, from Sigma, St. Louis, MO, United States; convulxin, sc-202554 from Santa Cruz Biotechnology, Santa Cruz, CA, United States) were added to each group before the start

(6) Platelet p110β mediates platelet-leukocyte interaction and curtails bacterial dissemination in pneumococcal pneumoniaCell reportsNovember 8, 2022Schrottmaier WC, Kral-Pointner JB, Salzmann M, Mussbacher M, Schmuckenschlager A, Pirabe A, Brunnthaler L, Kuttke M, Maier B, Heber S, et al.

(7) Neutrophil extracellular traps regulate ischemic stroke brain injuryThe Journal of clinical investigationMay 16, 2022Denorme F, Portier I, Rustad JL, Cody MJ, de Araujo CV, Hoki C, Alexander MD, Grandhi R, Dyer MR, Neal MD, et al.previously (66, 67), resuspended to 1 × 108 cells/mL in Medium 199, and activated with 50 ng/mL convulxin (sc-202554, Santa Cruz Biotechnology) for 15 minutes. Activated platelets and neutrophils were incubated at a 100:1

(8) Pannexin-1 Activation by Phosphorylation Is Crucial for Platelet Aggregation and Thrombus FormationInternational journal of molecular sciencesMay 2, 2022Metz LM, Elvers M.

(9) Adipose Triglyceride Lipase Deficiency Attenuates In Vitro Thrombus Formation without Affecting Platelet Activation and Bleeding In VivoCellsMarch 1, 2022Goeritzer M, Schlager S, Kuentzel KB, Vujić N, Korbelius M, Rainer S, Kolb D, Mussbacher M, Salzmann M, Schrottmaier WC, et al.

(10) Functional Assessment of Platelet Dense Granule ATP ReleaseAmerican journal of clinical pathologyMay 18, 2021Cho JH, Wool GD, Tjota MY, Gutierrez J, Mikrut K, Miller JL.

(11) COVID-19 patients exhibit reduced procoagulant platelet responsesJournal of thrombosis and haemostasis : JTHNovember 1, 2020Denorme F, Manne BK, Portier I, Petrey AC, Middleton EA, Kile BT, Rondina MT, Campbell RA.

(12) Genetic platelet depletion is superior in platelet transfusion compared to current modelsHaematologicaJune 1, 2020Salzmann M, Schrottmaier WC, Kral-Pointner JB, Mussbacher M, Volz J, Hoesel B, Moser B, Bleichert S, Morava S, Nieswandt B, et al.

(13) Nox2 NADPH oxidase is dispensable for platelet activation or arterial thrombosis in miceBlood advancesApril 23, 2019Sonkar VK, Kumar R, Jensen M, Wagner BA, Sharathkumar AA, Miller FJ Jr, Fasano M, Lentz SR, Buettner GR, Dayal S.

(14) Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbitsJournal of thrombosis and haemostasis : JTHMarch 1, 2019Lauritzen B, Olling J, Abel KL, Augustsson C, Balling K, Bjelke M, Hegelund AC, Hilden I.

(15) In vivo modeling of docosahexaenoic acid and eicosapentaenoic acid-mediated inhibition of both platelet function and accumulation in arterial thrombiPlateletsJanuary 1, 2019Adili R, Voigt EM, Bormann JL, Foss KN, Hurley LJ, Meyer ES, Veldman AJ, Mast KA, West JL, Whiteheart SW, et al.

(16) Structure⁻Activity Relationship Study of Newly Synthesized Iridium-III Complexes as Potential Series for Treating Thrombotic DiseasesInternational journal of molecular sciencesNovember 19, 2018Yang CH, Hsia CW, Jayakumar T, Sheu JR, Hsia CH, Khamrang T, Chen YJ, Manubolu M, Chang Y.

(17) Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasisThrombosis researchOctober 1, 2018Clarke AS, Rousseau E, Wang K, Kim JY, Murray BP, Bannister R, Matzkies F, Currie KS, Di Paolo JA.

(18) The small-molecule MERTK inhibitor UNC2025 decreases platelet activation and prevents thrombosisJournal of thrombosis and haemostasis : JTHFebruary 1, 2018Branchford BR, Stalker TJ, Law L, Acevedo G, Sather S, Brzezinski C, Wilson KM, Minson K, Lee-Sherick AB, Davizon-Castillo P, et al.

(19) Buddleja globosa (matico) prevents collagen-induced platelet activation by decreasing phospholipase C-gamma 2 and protein kinase C phosphorylation signalingJournal of traditional and complementary medicineJanuary 1, 2018Fuentes M, Sepúlveda C, Alarcón M, Palomo I, Fuentes E.

(20) Superoxide Dismutase 2 is dispensable for platelet functionThrombosis and haemostasisOctober 5, 2017Fidler TP, Rowley JW, Araujo C, Boudreau LH, Marti A, Souvenir R, Dale K, Boilard E, Weyrich AS, Abel ED.

Be the First to Write a Review!

Convulxin Chemicals

Convulxin from Santa Cruz Biotechnology, Inc.

Description

Santa Cruz Biotechnology, Inc.

Citations (32)

Reviews

Convulxin from Santa Cruz Biotechnology, Inc.

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map